{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:42:15Z","timestamp":1760298135005},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cardiovascular Prevention &amp; Rehabilitation"],"published-print":{"date-parts":[[2009,8]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p> Evidence about the efficacy of statin treatment among patients after percutaneous coronary intervention (PCI) is very limited. The rapid advancement in PCI technology and near universal use of adjunctive cardioprotective medications make it necessary to formally assess the effect of statin therapy on cardiac events after PCI. <\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p> This was a multicenter prospective cohort study. <\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p> Patients who received stent implantation and survived to hospital discharge from the National Heart, Lung, and Blood Institute Dynamic Registry from 2004 to 2006 formed the study cohort. Patients with cardiogenic shock, in-hospital adverse events [including myocardial infarction and coronary artery bypass graft surgery (CABG)], liver disease, renal disease, alcoholism, or drug abuse were excluded. The occurrences of death, CABG, and repeat PCI, and repeat revascularization were collected over 1-year follow-up. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p> Of the 3227 patients evaluated, 2737 (85%) were prescribed a statin at discharge. By 1-year follow-up, incident events were 98 deaths, 44 CABG, 290 repeat PCI procedures, and 328 repeat revascularizations. After propensity score adjustment, postdischarge statin therapy was associated with lower risks of death [hazard ratio (HR): 0.58, 95% confidence interval (CI): 0.36\u20130.93, P = 0.02], CABG (HR: 0.49, 95% CI: 0.24\u20131.00, P = 0.05), and repeat revascularization (HR: 0.74, 95% CI: 0.56\u20131.00, P = 0.05). <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p> These results support the routine use of statin therapy after PCI. <\/jats:p><\/jats:sec>","DOI":"10.1097\/hjr.0b013e32832a4e3b","type":"journal-article","created":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T03:30:58Z","timestamp":1248838258000},"page":"445-450","source":"Crossref","is-referenced-by-count":15,"title":["Beneficial effects of statins after percutaneous coronary intervention"],"prefix":"10.1093","volume":"16","author":[{"given":"Zhi-Jiang","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Epidemiology, School of Public Health, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Departments of Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar C.","family":"Marroquin","sequence":"additional","affiliation":[{"name":"Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel L.","family":"Weissfeld","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roslyn A.","family":"Stone","sequence":"additional","affiliation":[{"name":"Biostatistics, University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh R.","family":"Mulukutla","sequence":"additional","affiliation":[{"name":"Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David O.","family":"Williams","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faith","family":"Selzer","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin E.","family":"Kip","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Public Health, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,8,1]]},"reference":[{"key":"bibr1-HJR.0b013e32832a4e3b","first-page":"1383","volume":"344","author":"The Scandinavian Simvastatin Survival Study Group.","year":"1994","journal-title":"Lancet"},{"key":"bibr2-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811053391902"},{"key":"bibr3-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16936-5"},{"key":"bibr4-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.10.039"},{"key":"bibr5-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1161\/hc0602.103586"},{"key":"bibr6-HJR.0b013e32832a4e3b","first-page":"260","volume":"98","author":"Yamawaki T","year":"2007","journal-title":"Fukuoka Igaku Zasshi"},{"key":"bibr7-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.04.022"},{"key":"bibr8-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/70.1.41"},{"key":"bibr9-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1984.10478078"},{"key":"bibr10-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-200009000-00011"},{"key":"bibr11-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2006.01.028"},{"key":"bibr12-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1998.1150"},{"key":"bibr13-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411173312002"},{"key":"bibr14-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00259-3"},{"key":"bibr15-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.24.3215"},{"key":"bibr16-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00993.2003"},{"key":"bibr17-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.11.3172"},{"key":"bibr18-HJR.0b013e32832a4e3b","first-page":"627","volume":"98","author":"Guven GS","year":"2006","journal-title":"J Natl Med Assoc"},{"key":"bibr19-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.7.926"},{"key":"bibr20-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.643114"},{"key":"bibr21-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.13.jpc60002"},{"key":"bibr22-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.1997.0211"},{"key":"bibr23-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.83.5.490"},{"key":"bibr24-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66196-X"},{"key":"bibr25-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(99)00122-3"},{"key":"bibr26-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(91)90002-Y"},{"key":"bibr27-HJR.0b013e32832a4e3b","doi-asserted-by":"publisher","DOI":"10.1161\/hc2901.093188"}],"container-title":["European Journal of Cardiovascular Prevention &amp; Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/HJR.0b013e32832a4e3b","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1097\/HJR.0b013e32832a4e3b","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/HJR.0b013e32832a4e3b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T13:26:23Z","timestamp":1612445183000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/16\/4\/445-450\/5931804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["10.1097\/HJR.0b013e32832a4e3b"],"URL":"https:\/\/doi.org\/10.1097\/hjr.0b013e32832a4e3b","relation":{},"ISSN":["1741-8267"],"issn-type":[{"value":"1741-8267","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}